EP3666202A1 - Systems and methods for embolic implant detachment - Google Patents

Systems and methods for embolic implant detachment Download PDF

Info

Publication number
EP3666202A1
EP3666202A1 EP19215318.7A EP19215318A EP3666202A1 EP 3666202 A1 EP3666202 A1 EP 3666202A1 EP 19215318 A EP19215318 A EP 19215318A EP 3666202 A1 EP3666202 A1 EP 3666202A1
Authority
EP
European Patent Office
Prior art keywords
delivery tube
introducer sheath
interference feature
proximal end
length
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP19215318.7A
Other languages
German (de)
French (fr)
Other versions
EP3666202B1 (en
Inventor
David BLUMENSTYK
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DePuy Synthes Products Inc
Original Assignee
DePuy Synthes Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DePuy Synthes Products Inc filed Critical DePuy Synthes Products Inc
Publication of EP3666202A1 publication Critical patent/EP3666202A1/en
Application granted granted Critical
Publication of EP3666202B1 publication Critical patent/EP3666202B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743Type of operation; Specification of treatment sites
    • A61B2017/00778Operations on blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/01Filters implantable into blood vessels
    • A61F2/011Instruments for their placement or removal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0021Catheters; Hollow probes characterised by the form of the tubing
    • A61M2025/0042Microcatheters, cannula or the like having outside diameters around 1 mm or less
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/0067Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A61M2025/0079Separate user-activated means, e.g. guidewires, guide tubes, balloon catheters or sheaths, for sealing off an orifice, e.g. a lumen or side holes, of a catheter

Definitions

  • the present invention generally relates to aneurysm treatment devices and more particularly, to delivery systems for embolic implants.
  • Implant devices are known in the field. Many are deployed mechanically, via systems that combine one or more catheters and wires for delivery. Examples of implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures delivered through a microcatheter. Some obstetric and gastrointestinal implants may also be implanted via similar systems that combine one or more catheters and wires. Devices that may be released or deployed by mechanical means vary greatly in design but can employ a similar delivery catheter and wire system. Many such catheter-based delivery systems include a wire for retention of the implant in the catheter until the time for release of the device. These systems are then actuated by retracting or pulling the wire relative to the catheter. Such a wire is referred to herein as a "pull wire".
  • a physician can use one of many known deployment apparatuses.
  • Such mechanical deployment apparatuses are typically separate from the delivery system and have moving parts for gripping the pull wire and for moving the pull wire proximally.
  • Deployment methods and apparatuses that do not require auxiliary components and/or complex moving parts can simplify treatment procedures and reduce cost. There is therefore a need for simplified mechanical implant deployment apparatuses.
  • Examples can generally include an embolic implantation system that includes an embolic implant, a delivery system, and an introducer sheath that are collectively designed so that the combination of the introducer sheath and the delivery system can be used as a deployment apparatus for the embolic implant.
  • the delivery system can have a pull wire, a delivery tube, and an interference feature attached to the pull wire and positioned at a proximal end of the delivery tube.
  • the introducer sheath can be moved proximally over the delivery tube until it engages the interference feature.
  • the introducer sheath can be pressed against the interference feature, causing the interference feature to move proximally in relation to the delivery tube, thereby proximally pulling the pull wire to which the interference feature is attached and deploying the implant.
  • An example implantation system can include a delivery tube, an embolic coil, an introducer sheath, an interference feature, and an elongated member.
  • the embolic coil can be detachably attached to a distal end of the delivery tube.
  • the interference feature can be positioned at a proximal end of the delivery tube and movable in relation to the delivery tube.
  • the elongated member can be positioned within a lumen of the delivery tube and attached to the interference feature.
  • the introducer sheath can have a lumen sized to slidably receive the delivery tube and the embolic coil, the introducer sheath can be translatable over the delivery tube from the distal end of the delivery tube to the proximal end of the delivery tube, and the introducer sheath can be sized to engage the interference feature.
  • the interference feature can be movable in relation to the delivery tube in response to a force applied by the introducer sheath against the interference feature.
  • the elongated member can be movable in relation to the delivery tube in response to a proximal movement of the interference feature.
  • the interference feature can be detachable from the delivery tube.
  • the elongated member can be movable to exit the proximal end of the delivery tube in response to a proximal movement of the detached interference feature.
  • the delivery tube can have a soft section near the distal end of the delivery tube.
  • the length of the embolic coil and the soft section as measured from a distal end of the un-implanted embolic coil to a proximal end of the soft section can be shorter than the end-to-end length of the introducer sheath so that the introducer sheath is sized to fully encompass the un-implanted embolic coil and the soft section.
  • the introducer sheath can be longer than the length of the embolic coil and soft section by about 5 cm.
  • the system can include a microcatheter, and the delivery tube can have an end-to-end length that is longer than the sum of the end-to-end length of the introducer sheath and an end-to-end length of the microcatheter.
  • the end-to-end length of the introducer sheath can be between about 46 cm to about 105 cm.
  • the introducer sheath can be movable from a packaged configuration in which the introducer sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the introducer sheath is engaged with the interference feature.
  • the embolic coil can be detached from the delivery tube by moving the elongated member proximally in relation to the delivery tube.
  • the interference feature can have a substantially circular surface positioned to engage the proximal end of the introducer sheath.
  • a distal end of the introducer sheath can be sized to engage a microcatheter to create an enclosed interface through which the embolic coil and at least a portion of the delivery tube can pass.
  • An example implantation assembly can include a delivery tube, an embolic implant, a pull wire, an engagement bump, and a tubular sheath.
  • the embolic implant can be attached to a distal end of the delivery tube.
  • the pull wire can be disposed within a lumen of the delivery tube and movable to detach the embolic implant from the delivery tube.
  • the engagement bump can be disposed on a proximal end of the pull wire and positioned near a proximal end of the delivery tube.
  • the tubular sheath can be conveyable over the embolic implant and the delivery tube from a distal end of the embolic implant to the proximal end of the delivery tube, and the tubular sheath can be sized to engage the engagement bump.
  • the engagement bump and the pull wire can be movable in relation to the delivery tube in response to a force applied by the tubular sheath to the engagement bump.
  • the delivery tube can have a soft section extending proximally from the distal end of the delivery tube, and the tubular sheath can measure end-to-end about 5 cm longer than a length measured from a distal end of the embolic implant to a proximal end of the soft section when the embolic implant is attached to the delivery tube and extended in an un-implanted configuration.
  • the assembly can include a microcatheter, and the delivery tube can have an end-to-end length that is greater than the sum of the length of the introducer sheath and the microcatheter.
  • the tubular sheath can be movable from a packaged configuration in which the tubular sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the tubular sheath is engaged with the engagement bump.
  • the engagement bump can be detachable from the delivery tube in response to the force applied by the tubular sheath to the engagement bump.
  • the pull wire can be movable to detach the embolic implant from the delivery tube in response to the force applied by the tubular sheath to the engagement bump.
  • An example method for treating an aneurysm can include the steps of providing an implantation system including an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire; affixing the pull wire to the interference feature; positioning the pull wire within a lumen of the delivery tube; attaching the interference feature to a proximal end of the delivery tube; attaching the embolic implant at a distal end of the delivery tube; positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube; sliding the introducer sheath proximally over the delivery tube; pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; and moving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
  • the first portion of the delivery tube over which the introducer sheath is positioned in the example method can have a soft section.
  • the method can include sizing the introducer sheath to have a length that is greater than the length of the embolic implant and the soft section by about 5 cm.
  • the method can include sizing the introducer sheath to have a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
  • the method can include detaching the embolic implant from the delivery tube in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
  • the method can include detaching the interference feature from the delivery tube.
  • the interference feature can be detached in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
  • the method can include providing a microcatheter; positioning the introducer sheath to engage with the microcatheter while maintaining the embolic implant and the first portion of the delivery tube within the inducer sheath; and translating the embolic implant and the delivery tube distally to position the embolic implant and the first portion of the delivery tube within the microcatheter.
  • Examples presented herein utilize an introducer sheath to facilitate mechanical deployment of an implant.
  • implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures deliverable through a microcatheter.
  • Some implants are currently packaged with an introducer sheath that is removed from the device and discarded near the beginning of an implantation procedure.
  • embolic coils and other embolic implants can be used to occlude vessels in a variety of medical applications.
  • the embolic implant is contained in an introducer sheath.
  • the introducer sheath In present treatment practices, once the embolic implant is transferred to a microcatheter, the introducer sheath would be removed from the delivery system and discarded before the embolic implant reaches a treatment site.
  • the introducer sheath can be slid proximally and can facilitate deployment of the embolic implant, i.e. detachment of the embolic implant from the delivery system.
  • the delivery system can have an interference feature positioned at a proximal end of a delivery tube and attached to a pull wire, and the combination of the introducer sheath, delivery tube, pull wire, and interference feature can be configured such that the introducer sheath can engage with the interference feature and move the interference feature proximally in relation to the delivery tube, thereby pulling the pull wire proximally and deploying the embolic implant.
  • the delivery tube, microcatheter, and introducer sheath can each have a respective length sized such that the introducer sheath can be long enough to cover the embolic implant and sensitive portions of the delivery system, and the delivery tube can be long enough to extend through the entire length of the microcatheter and the entire length of the introducer sheath.
  • FIG. 1 is an illustration of an exemplary implantation system 100.
  • the implantation system 100 can have an embolic implant 140 such as an embolic coil, embolic braid, or other such implant for filling an aneurysm sac, a delivery tube 110 for delivering the embolic implant 140 to a treatment site, a pull wire 130 disposed within the delivery tube that can be pulled proximally to deploy the embolic implant 140, an interference feature 120 positioned at a proximal end 112 of the delivery tube 110 attached to the pull wire 130 that can be pulled proximally to pull the pull wire 130 proximally, and an introducer sheath 180 that can be moved proximally to engage the interference feature 120 and pull the interference feature 120 proximally.
  • an embolic implant 140 such as an embolic coil, embolic braid, or other such implant for filling an aneurysm sac
  • a delivery tube 110 for delivering the embolic implant 140 to a treatment site
  • a pull wire 130 disposed within the delivery tube
  • the introducer sheath 180 can have a lumen therethrough that is sized to slidably receive the delivery tube 110 and the embolic implant 140.
  • the introducer sheath 180 can be sized such that it can be translated proximally from the position illustrated in FIG. 1 over a length of the delivery tube 110 to engage the interference feature 120 positioned at the proximal end 112 of the delivery tube 110.
  • the interference feature 120 can be movable in relation to the delivery tube 110.
  • the interference feature 120 can be detachably attached to the proximal end 112 of the delivery tube 110, and the system 100 can include a disconnection feature 122 that can be unhooked, torn, broken, twisted, or otherwise manipulated to disconnect the interference feature 120 from the delivery tube 110.
  • the delivery tube 110 can have a soft section 116 positioned near a distal end 114 of the delivery tube 110 that has a greater flexibility than the remainder (proximal portion) 118 of the delivery tube 110.
  • the embolic implant 140 can be detachably attached to a distal end 114 of the delivery tube 114.
  • the soft section 116 can be designed to allow greater control and stability of the distal end 114 of the delivery tube 110 during implantation and deployment of the embolic implant 140.
  • the soft section 116 can have laser cut notches or groves, and/or the soft section 116 can be made of a more flexible material compared to the remainder 118 of the delivery tube 110.
  • the introducer sheath 180 can serve the purpose of protecting (packaging) the embolic implant 140 and the soft section 116 of the delivery tube 110 as the system 100 is being handled prior to, and at the beginning of a patient treatment procedure. For this purpose, it is therefore desirable for the introducer sheath 180 to be long enough to completely encompass the embolic implant 140 and the soft section 116 prior to the treatment procedure.
  • the combined length of the embolic implant 140 and the soft section 116 can be measured from a distal end 144 of the embolic implant 140 to a proximal end 117 of the soft section 116.
  • the introducer sheath 180 can have a length measurable from a distal end 184 to a proximal end 182 of the introducer sheath that can be sized a few centimeters longer than the combined length of the embolic implant 140 and the soft section 116 to ensure that the embolic implant 140 and soft section 116 remain protected in case portions of the system 100 shift during handling prior to the treatment procedure.
  • the introducer sheath 180 can have a length that is about 5 cm longer than the combined length of the embolic implant 140 and the soft section 116.
  • the embolic implant 140 can have a length of between about 1 cm and about 60 cm, the soft section 116 can have a length of about 40 cm, and the introducer sheath can have a length that is about 5 cm longer than the sum of the embolic implant 140 length and the soft section 116 length, i.e. between about 46 cm and about 105 cm.
  • FIGs. 2A and 2B are illustrations of an exemplary implantation system such as illustrated in FIG. 1 interfacing with a microcatheter 200.
  • FIG. 2A illustrates an instant of a treatment procedure near the beginning of the treatment procedure in which an introducer sheath 180 is positioned to cover an embolic implant 140 and a soft portion 116 of a delivery tube 110 in a packaged configuration and a distal end 184 of the introducer sheath 180 is mated or engaged with a proximal end of the microcatheter 200. As shown in FIG.
  • the distal end 184 of the introducer sheath 180 can be sized to engage the microcatheter 200 to create an enclosed interface through which the embolic implant 140 and the soft portion 116 of the delivery tube 110 can pass.
  • the embolic implant 140 and the delivery tube 110 can be translated distally to push the embolic implant 140 and a portion of the delivery tube 110 into the microcatheter 200.
  • FIG. 2B illustrates an instant of the treatment procedure in which the embolic implant 140 and the soft portion 116 are positioned within the microcatheter 200.
  • the embolic implant 140 and the soft portion 116 are protected by the microcatheter 200 and the introducer sheath can now be pulled proximally 180 or left in place as the delivery tube 110 and embolic implant 140 are further translated distally.
  • FIGs. 3A through 3C are illustrations of an exemplary implantation system during a series of example implantation steps.
  • FIG. 3A illustrates an embolic implant 140 and a soft portion 116 of a delivery tube 110 positioned inside a microcatheter 200 and an introducer sheath 180 being translated proximally over a proximal portion 118 of the delivery tube 110.
  • the introducer sheath 180 can be disengaged from the microcatheter 200 and pulled proximally once the embolic implant 140 and soft section 116 are protected within the microcatheter 200, but before the embolic implant 140 is positioned at a treatment site or within an aneurysm.
  • the introducer sheath 180 can remain engaged to the microcatheter until the embolic implant 140 is positioned at the treatment site or ready to be deployed from the delivery tube 110 and then pulled proximally after the embolic implant 140 is positioned at the treatment site.
  • FIG. 3B illustrates the introducer sheath 180 in a deployment configuration in which the introducer sheath 180 is engaged with an interference feature 120 positioned near a proximal end 112 of the delivery tube 110.
  • the introducer sheath 180 is shown providing a force F against the interference feature 120.
  • the force can be sufficient to move the interference feature 120 proximally in relation to the delivery tube 110.
  • the interference feature 120 Prior to the application of the force F, the interference feature 120 can be detachably attached to the proximal end 112 of the delivery tube 110, and the interference feature 120 can be detached from the proximal end 112 of the delivery tube 110 in response to the force F.
  • the interference feature 120 can remain attached to the delivery tube 110 and the force F can be sufficient to move the interference feature 120 in relation to the delivery tube 110.
  • the introducer sheath 180 can be sized to engage the interference feature 120.
  • the introducer sheath 180 can be tubular and can have a circular proximal end 182, and the interference feature 120 can protrude radially beyond a circumference of the delivery tube 110.
  • the interference feature 120 can be circular, having a circumference larger than a circumference of the proximal end 182 of the introducer sheath 180.
  • the interference feature 120 can provide a flat surface against which the proximal end 182 of the introducer sheath 180 can press. Additionally, or alternatively, the interference feature can have a non-flat surface that can have a slope or a groove for receiving the introducer sheath 180.
  • the interference feature 120 can be a bump positioned near the distal end of the delivery tube that extends beyond the circumference of the delivery tube and extends so that the introducer sheath 180, when slid proximally over the delivery tube 110, must engage the interreference feature 120 before sliding completely over and off the proximal end 112 of the delivery tube 110.
  • FIG. 3C illustrates the interference feature 120 after being moved proximally in relation to the delivery tube 110 in response to the force F from the introducer sheath 180.
  • the interference feature 120 can be attached to a pull wire 130, and the pull wire 130 can be pulled proximally when the interference feature 180 is moved proximally.
  • the interference feature 120 can be detachably attached to the delivery tube 110 prior to the proximal movement of the interference feature 120, and a detachment feature 122 can be manipulated to facilitate the detachment of the interference feature 120.
  • the interference feature 120 can be pulled proximally away from the delivery tube 110, and the pull wire 130 can be moved to exit the proximal end 112 of the delivery tube 110 in response to the pulling of the interference feature 120.
  • the pull wire 130 can be an elongated member that extends through a lumen of the delivery tube 110 toward the embolic implant 140.
  • the pull wire 130 can constitute a component of a deployment system for releasing the embolic implant 140 at the distal end 114 of the delivery tube 110.
  • the pull wire 130 can initiate the deployment of the embolic implant 140.
  • the embolic implant 140 can be detached from the delivery tube 110 in response to the proximal movement of the pull wire 130 in relation to the delivery tube 110.
  • FIG. 4A illustrates an exemplary implantation system having a breakable disconnection feature 122a.
  • the implantation system can have an interference feature 120 detachably attached to a delivery tube 110 by the breakable disconnection feature 122a.
  • the delivery tube 110 can include notches 115 that are areas in which material is removed from the delivery tube 110.
  • the notches 115 can be positioned at a proximal end 112 of the delivery tube 110.
  • the proximal end 112 of the delivery tube 110 can be attached to the interference feature 120 by gluing, welding, or other means.
  • the notches 115 can be a breakable section 122a of the delivery tube 110.
  • FIG. 4B is a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 4A .
  • FIG. 5A illustrates an exemplary implantation system having a twist-lock disconnection feature 122b.
  • the implantation system can have a delivery tube 110 with groove 113 cut at a proximal end 112 and an interference feature 120 that has a bump 123 or another feature that can engage the groove 113.
  • the interference feature 120 can be detachably attached to the delivery tube 110 by the twist-lock disconnection feature (and/or a bayonet connector) 122b.
  • the interference feature 120 can extend within a lumen of the delivery tube 110 at the proximal end 112 of the delivery tube 110 and have a bump or protrusion 123 that can be positioned in the groove 113 in the delivery tube 110 to maintain the attachment between the interference feature 120 and the delivery tube 110.
  • FIG. 5B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 5A .
  • FIGs. 4A through 5B illustrate examples of an interference feature 120 that is movable in relation to the delivery tube 110 after detaching from the delivery tube 110
  • the interference feature need not be detached, and can be movable in relation to the delivery tube 110 without detaching.
  • FIGs. 6A through 8C illustrate example systems wherein the interference feature 120 remains at least partially attached to the delivery tube 110.
  • FIG. 6A illustrates an exemplary implantation system having a sliding track 113a and a bump or protrusion 123a.
  • the sliding track 113a can be cut from a portion of the delivery tube 110 near the proximal end 112 of the delivery tube 110.
  • the interference feature 120 can have an engagement bump or protrusion 123a that is positioned to slide within the track 113a.
  • the track 113a can extend along a portion of a length of the delivery tube 110, and the bump 123a can slide within the track 113a, allowing the interference feature 120 to move in a proximal direction in relation to the delivery tube 110.
  • the track 113a can be L shaped, and the interference feature 120 can be twisted in relation to the delivery tube 110 and then pulled proximally in relation to the delivery tube 110 to move the interference feature 120 in relation to the delivery tube 110.
  • the interference feature 120 can be attached to a pull wire 130, and the movement of the interference feature 120 can move the pull wire 130 to deploy an embolic implant 140.
  • FIG. 6B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 6A .
  • FIG. 7A illustrates an exemplary implantation system having a stretchable segment 126.
  • the implantation system can have a delivery tube 110 with a stretchable segment 126 positioned near a proximal end 112 of the delivery tube 110.
  • the stretchable segment 126 can be a region of the delivery tube 110 that has a propensity to stretch in response to a force that creates tension along a length of the delivery tube 110 that includes the stretchable segment 126.
  • the stretchable segment 126 can include a coil that is compressed in an initial state as illustrated in FIG. 7A , a laser cut portion of the tube, and/or a portion of tubing having greater elasticity.
  • the stretchable segment 126 can extends in response to a force provided by the introducer sheath 180 against the interference feature 120.
  • the stretchable segment 126 can allow the pull wire and the interference feature 120 to move proximally in relation to the delivery tube 110 without the interference feature 120 becoming disconnected from the delivery tube 110.
  • the stretchable segment 126 can have a fully extended length that is determined by the material properties and/or construction of the stretchable segment 126. The fully extended length can limit the distance that the interference feature 120 can be moved proximally in relation to the delivery tube 110.
  • FIG. 7B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 7A .
  • FIGs. 8A through 8C illustrate an exemplary implantation system having a stretchable element 126a and a detachment feature 122c.
  • the disconnection feature 122c illustrated in FIGs. 8A through 8C can include notches 115B in a delivery tube 110, similar to that illustrated in FIGs. 4 and 4B . It is contemplated that other disconnection features, including the disconnection features illustrated in, and described in relation to FIGs. 1 , 3A-3C , 5, or 5B could be combined with a stretchable segment like those described herein or otherwise known.
  • the disconnection feature 122c can be positioned along a length of the delivery tube 110 at or near the stretchable segment 126a. Both the stretchable segment 126a and the disconnection feature 122c can be positioned near the proximal end 112 of the delivery tube 110.
  • FIG. 8A illustrates the stretchable element 126a positioned within a lumen of the delivery tube 110 near the proximal end 112 of the delivery tube 110.
  • the delivery tube 110 is illustrated cut-away to show coils of the stretchable element 126a within.
  • interference feature 120 can be attached to the delivery tube 110 via the stretchable element 126a and the detachment feature 122c.
  • FIG. 8B illustrates an introducer sheath 180 moved proximally to engage the interference feature 120, break the detachment feature 122c, and begin to stretch the stretchable element 126a.
  • the delivery tube 110 and the introducer sheath 180 are shown cut-away.
  • a pull wire 130 can be positioned within the delivery tube 110. The pull wire 130 can be pulled proximally as the interference feature 120 is moved proximally.
  • the stretchable element 126a can be attached to the interference feature 120 with a weld, adhesive, or other connection 125.
  • the stretchable element 126a can be attached to the delivery tube 110 with a weld, adhesive, or other connection 127. After the detachment feature 122c is detached, the stretchable element 126a can maintain an attachment between the interference feature 120 and the delivery tube 110.
  • FIG. 8C illustrates the introducer sheath 180 moved further proximally to move the interference feature 120 and pull wire 130 further proximally and further stretch the stretchable element 126a.
  • the stretchable element 126a can have a fully extended length that is determined by the material properties and/or construction of the stretchable element 126a. The fully extended length can limit the distance that the interference feature 120 can be moved proximally in relation to the delivery tube 110.
  • FIG. 9 illustrates relative dimensions of a delivery system, microcatheter, and introducer sheath as known in the art.
  • Known delivery systems are typically 200 cm long, known microcatheters are typically 165 cm long, and known introducer sheaths are typically 130 cm long.
  • the introducer sheath is typically removed after an embolic implant and any sensitive portions of the delivery system are inserted into the microcatheter. According to known practices, an introducer sheath cannot remain around the delivery system during the deployment step of the embolic implant because the combined length of known microcatheters and introducers is several centimeters longer than known delivery systems.
  • an implantation system can include a delivery system, microcatheter, and introducer sheath, wherein the delivery system is longer than the combined length of the microcatheter and the introducer sheath.
  • An aneurysm can be treated with an implantation system such as any of the implantation systems disclosed herein in relation to the present invention by executing some or all the following steps, not necessarily in order.
  • An implantation system 100 having an embolic implant 140, an introducer sheath 180, a delivery tube 110, an interference feature 120, and a pull wire 130 can be provided.
  • the pull wire 130 can be affixed to the interference feature 120.
  • the pull wire 130 can be positioned within a lumen of the delivery tube 110.
  • the interference feature 120 can be attached to a proximal end 112 of the delivery tube 110.
  • the embolic implant 140 can be attached at a distal end 114 of the delivery tube 110.
  • the introducer sheath 180 can be positioned to encompass the embolic implant 140 and a first portion of the delivery tube 110.
  • the first portion of the delivery tube 110 can comprise a soft section 116.
  • the introducer sheath can be sized to have an end-to-end length that is longer by about 5 cm than a length measurable from a distal end 144 of the embolic implant 140 to a proximal end 117 of the soft section 116.
  • the introducer sheath 180 can be sized so that the end-to-end length is between about 46 cm and about 105 cm.
  • a microcatheter 200 can be provided.
  • the introducer sheath 180 can be positioned to engage with the microcatheter 200 while maintaining the embolic implant 140 and the first portion of the delivery tube 110 within the introducer sheath 180.
  • the embolic implant 140 and the delivery tube 110 can be translated distally to position the embolic implant 140 and the first portion of the delivery tube 110 within the microcatheter 200.
  • the introducer sheath 180 can be slid proximally over the delivery tube 110.
  • the introducer sheath 180 can be pulled proximally to apply a force from the introducer sheath 180 to the interference feature 120.
  • the interference feature 120 and the pull wire 130 can be moved proximally in relation to the delivery tube 110 in response to the force.
  • the interference feature 120 can be detached from the delivery tube 110.
  • the embolic implant 140 can be detached from the delivery tube 110 in response to moving the interference feature 120 and the pull wire 130 proximally in relation to the delivery tube 110.
  • the methods described herein may be not methods for the treatment of the human or animal body by surgery or therapy.
  • the methods may be ex vivo and/or in vitro methods e.g. methods taking place in a laboratory and/or for testing.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Vascular Medicine (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Surgical Instruments (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

An aneurysm treatment system (100) that includes an embolic implant (140), a delivery system, and an introducer sheath (180) that are collectively designed so that the combination of the introducer sheath (180) and the delivery system can be used as a deployment apparatus for the embolic implant (140). The delivery system can have a pull wire (130), a delivery tube (110), and an interference feature (120) attached to the pull wire (130) and positioned near a proximal end of the delivery tube (110). Rather than being discarded, the introducer sheath (180) can be moved proximally over the delivery tube (110) until it engages the interference feature (120). To deploy the implant (140), the introducer sheath (180) can be pressed against the interference feature (120), causing the interference feature (120) to move proximally in relation to the delivery tube (110), thereby proximally pulling the pull wire (130) to which the interference feature (120) is attached and deploying the implant (140).

Description

    Field of Invention
  • The present invention generally relates to aneurysm treatment devices and more particularly, to delivery systems for embolic implants.
  • Background
  • Numerous intravascular implant devices are known in the field. Many are deployed mechanically, via systems that combine one or more catheters and wires for delivery. Examples of implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures delivered through a microcatheter. Some obstetric and gastrointestinal implants may also be implanted via similar systems that combine one or more catheters and wires. Devices that may be released or deployed by mechanical means vary greatly in design but can employ a similar delivery catheter and wire system. Many such catheter-based delivery systems include a wire for retention of the implant in the catheter until the time for release of the device. These systems are then actuated by retracting or pulling the wire relative to the catheter. Such a wire is referred to herein as a "pull wire".
  • To pull the pull wire proximally to deploy the implant, a physician can use one of many known deployment apparatuses. Such mechanical deployment apparatuses are typically separate from the delivery system and have moving parts for gripping the pull wire and for moving the pull wire proximally. Deployment methods and apparatuses that do not require auxiliary components and/or complex moving parts can simplify treatment procedures and reduce cost. There is therefore a need for simplified mechanical implant deployment apparatuses.
  • Summary
  • Disclosed herein are various exemplary systems, devices, and methods of the present invention that can address the above needs. Examples can generally include an embolic implantation system that includes an embolic implant, a delivery system, and an introducer sheath that are collectively designed so that the combination of the introducer sheath and the delivery system can be used as a deployment apparatus for the embolic implant. The delivery system can have a pull wire, a delivery tube, and an interference feature attached to the pull wire and positioned at a proximal end of the delivery tube. The introducer sheath can be moved proximally over the delivery tube until it engages the interference feature. To deploy the implant, the introducer sheath can be pressed against the interference feature, causing the interference feature to move proximally in relation to the delivery tube, thereby proximally pulling the pull wire to which the interference feature is attached and deploying the implant.
  • An example implantation system can include a delivery tube, an embolic coil, an introducer sheath, an interference feature, and an elongated member. The embolic coil can be detachably attached to a distal end of the delivery tube. The interference feature can be positioned at a proximal end of the delivery tube and movable in relation to the delivery tube. The elongated member can be positioned within a lumen of the delivery tube and attached to the interference feature. The introducer sheath can have a lumen sized to slidably receive the delivery tube and the embolic coil, the introducer sheath can be translatable over the delivery tube from the distal end of the delivery tube to the proximal end of the delivery tube, and the introducer sheath can be sized to engage the interference feature. The interference feature can be movable in relation to the delivery tube in response to a force applied by the introducer sheath against the interference feature. The elongated member can be movable in relation to the delivery tube in response to a proximal movement of the interference feature.
  • The interference feature can be detachable from the delivery tube. The elongated member can be movable to exit the proximal end of the delivery tube in response to a proximal movement of the detached interference feature.
  • The delivery tube can have a soft section near the distal end of the delivery tube. The length of the embolic coil and the soft section as measured from a distal end of the un-implanted embolic coil to a proximal end of the soft section can be shorter than the end-to-end length of the introducer sheath so that the introducer sheath is sized to fully encompass the un-implanted embolic coil and the soft section. The introducer sheath can be longer than the length of the embolic coil and soft section by about 5 cm.
  • The system can include a microcatheter, and the delivery tube can have an end-to-end length that is longer than the sum of the end-to-end length of the introducer sheath and an end-to-end length of the microcatheter.
  • The end-to-end length of the introducer sheath can be between about 46 cm to about 105 cm.
  • The introducer sheath can be movable from a packaged configuration in which the introducer sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the introducer sheath is engaged with the interference feature.
  • The embolic coil can be detached from the delivery tube by moving the elongated member proximally in relation to the delivery tube.
  • The interference feature can have a substantially circular surface positioned to engage the proximal end of the introducer sheath.
  • A distal end of the introducer sheath can be sized to engage a microcatheter to create an enclosed interface through which the embolic coil and at least a portion of the delivery tube can pass.
  • An example implantation assembly can include a delivery tube, an embolic implant, a pull wire, an engagement bump, and a tubular sheath. The embolic implant can be attached to a distal end of the delivery tube. The pull wire can be disposed within a lumen of the delivery tube and movable to detach the embolic implant from the delivery tube. The engagement bump can be disposed on a proximal end of the pull wire and positioned near a proximal end of the delivery tube. The tubular sheath can be conveyable over the embolic implant and the delivery tube from a distal end of the embolic implant to the proximal end of the delivery tube, and the tubular sheath can be sized to engage the engagement bump. The engagement bump and the pull wire can be movable in relation to the delivery tube in response to a force applied by the tubular sheath to the engagement bump.
  • The delivery tube can have a soft section extending proximally from the distal end of the delivery tube, and the tubular sheath can measure end-to-end about 5 cm longer than a length measured from a distal end of the embolic implant to a proximal end of the soft section when the embolic implant is attached to the delivery tube and extended in an un-implanted configuration.
  • The assembly can include a microcatheter, and the delivery tube can have an end-to-end length that is greater than the sum of the length of the introducer sheath and the microcatheter.
  • The tubular sheath can be movable from a packaged configuration in which the tubular sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the tubular sheath is engaged with the engagement bump.
  • The engagement bump can be detachable from the delivery tube in response to the force applied by the tubular sheath to the engagement bump. The pull wire can be movable to detach the embolic implant from the delivery tube in response to the force applied by the tubular sheath to the engagement bump.
  • An example method for treating an aneurysm can include the steps of providing an implantation system including an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire; affixing the pull wire to the interference feature; positioning the pull wire within a lumen of the delivery tube; attaching the interference feature to a proximal end of the delivery tube; attaching the embolic implant at a distal end of the delivery tube; positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube; sliding the introducer sheath proximally over the delivery tube; pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; and moving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
  • The first portion of the delivery tube over which the introducer sheath is positioned in the example method can have a soft section. The method can include sizing the introducer sheath to have a length that is greater than the length of the embolic implant and the soft section by about 5 cm. The method can include sizing the introducer sheath to have a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
  • The method can include detaching the embolic implant from the delivery tube in response to moving the interference feature and the pull wire proximally in relation to the delivery tube. The method can include detaching the interference feature from the delivery tube. The interference feature can be detached in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
  • The method can include providing a microcatheter; positioning the introducer sheath to engage with the microcatheter while maintaining the embolic implant and the first portion of the delivery tube within the inducer sheath; and translating the embolic implant and the delivery tube distally to position the embolic implant and the first portion of the delivery tube within the microcatheter.
  • Brief Description of the Drawings
  • The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.
    • FIG. 1 is an illustration of an exemplary implantation system according to aspects of the present invention;
    • FIGs. 2A and 2B are illustrations of an exemplary implantation system such as illustrated in FIG. 1 interfacing with a microcatheter according to aspects of the present invention;
    • FIGs. 3A through 3C are illustrations of implantation steps that can be performed with an exemplary implantation system such as illustrated in FIG. 1 according to aspects of the present invention;
    • FIG. 4A illustrates an exemplary implantation system having a breakable disconnection feature according to aspects of the present invention;
    • FIG. 4B illustrates a cross-sectional view near a proximal end of the exemplary implantation system of FIG. 4A as indicated in FIG. 4A and according to aspects of the present invention;
    • FIG. 5A illustrates an exemplary implantation system having a twist-lock disconnection feature according to aspects of the present invention;
    • FIG. 5B illustrates a cross-sectional view near a proximal end of the exemplary implantation system of FIG. 5A as indicated in FIG. 5A and according to aspects of the present invention;
    • FIG. 6A illustrates an exemplary implantation system having a sliding track according to aspects of the present invention;
    • FIG. 6B illustrates a cross-sectional view near a proximal end of the exemplary implantation system of FIG. 6A as indicated in FIG. 6A and according to aspects of the present invention;
    • FIG. 7A illustrates an exemplary implantation system having a stretchable segment according to aspects of the present invention;
    • FIG. 7B illustrates a cross-sectional view near a proximal end of the exemplary implantation system of FIG. 7A as indicated in FIG. 7A and according to aspects of the present invention;
    • FIGs. 8A through 8C illustrate cut-away views of an exemplary implantation system having a stretchable segment and a disconnecting feature according to aspects of the present invention; and
    • FIG. 9 illustrates relative dimensions of a delivery system, microcatheter, and introducer sheath as known in the art.
    Detailed Description
  • Examples presented herein utilize an introducer sheath to facilitate mechanical deployment of an implant. Examples of implants that can be delivered mechanically include embolic elements, stents, grafts, drug delivery implants, flow diverters, filters, stimulation leads, sensing leads, or other implantable structures deliverable through a microcatheter. Some implants are currently packaged with an introducer sheath that is removed from the device and discarded near the beginning of an implantation procedure. For example, in existing systems, embolic coils and other embolic implants can be used to occlude vessels in a variety of medical applications. In many instances, prior to implantation and during handling of an embolic implant outside of a patient, the embolic implant is contained in an introducer sheath. In present treatment practices, once the embolic implant is transferred to a microcatheter, the introducer sheath would be removed from the delivery system and discarded before the embolic implant reaches a treatment site. In examples presented herein, according to the present invention, rather than being discarded, the introducer sheath can be slid proximally and can facilitate deployment of the embolic implant, i.e. detachment of the embolic implant from the delivery system. In order to use the introducer sheath to facilitate deployment, the delivery system can have an interference feature positioned at a proximal end of a delivery tube and attached to a pull wire, and the combination of the introducer sheath, delivery tube, pull wire, and interference feature can be configured such that the introducer sheath can engage with the interference feature and move the interference feature proximally in relation to the delivery tube, thereby pulling the pull wire proximally and deploying the embolic implant. The delivery tube, microcatheter, and introducer sheath can each have a respective length sized such that the introducer sheath can be long enough to cover the embolic implant and sensitive portions of the delivery system, and the delivery tube can be long enough to extend through the entire length of the microcatheter and the entire length of the introducer sheath.
  • FIG. 1 is an illustration of an exemplary implantation system 100. The implantation system 100 can have an embolic implant 140 such as an embolic coil, embolic braid, or other such implant for filling an aneurysm sac, a delivery tube 110 for delivering the embolic implant 140 to a treatment site, a pull wire 130 disposed within the delivery tube that can be pulled proximally to deploy the embolic implant 140, an interference feature 120 positioned at a proximal end 112 of the delivery tube 110 attached to the pull wire 130 that can be pulled proximally to pull the pull wire 130 proximally, and an introducer sheath 180 that can be moved proximally to engage the interference feature 120 and pull the interference feature 120 proximally.
  • The introducer sheath 180 can have a lumen therethrough that is sized to slidably receive the delivery tube 110 and the embolic implant 140. The introducer sheath 180 can be sized such that it can be translated proximally from the position illustrated in FIG. 1 over a length of the delivery tube 110 to engage the interference feature 120 positioned at the proximal end 112 of the delivery tube 110.
  • The interference feature 120 can be movable in relation to the delivery tube 110. For example, the interference feature 120 can be detachably attached to the proximal end 112 of the delivery tube 110, and the system 100 can include a disconnection feature 122 that can be unhooked, torn, broken, twisted, or otherwise manipulated to disconnect the interference feature 120 from the delivery tube 110.
  • The delivery tube 110 can have a soft section 116 positioned near a distal end 114 of the delivery tube 110 that has a greater flexibility than the remainder (proximal portion) 118 of the delivery tube 110. The embolic implant 140 can be detachably attached to a distal end 114 of the delivery tube 114. The soft section 116 can be designed to allow greater control and stability of the distal end 114 of the delivery tube 110 during implantation and deployment of the embolic implant 140. The soft section 116 can have laser cut notches or groves, and/or the soft section 116 can be made of a more flexible material compared to the remainder 118 of the delivery tube 110.
  • The introducer sheath 180 can serve the purpose of protecting (packaging) the embolic implant 140 and the soft section 116 of the delivery tube 110 as the system 100 is being handled prior to, and at the beginning of a patient treatment procedure. For this purpose, it is therefore desirable for the introducer sheath 180 to be long enough to completely encompass the embolic implant 140 and the soft section 116 prior to the treatment procedure. The combined length of the embolic implant 140 and the soft section 116 can be measured from a distal end 144 of the embolic implant 140 to a proximal end 117 of the soft section 116. The introducer sheath 180 can have a length measurable from a distal end 184 to a proximal end 182 of the introducer sheath that can be sized a few centimeters longer than the combined length of the embolic implant 140 and the soft section 116 to ensure that the embolic implant 140 and soft section 116 remain protected in case portions of the system 100 shift during handling prior to the treatment procedure. The introducer sheath 180 can have a length that is about 5 cm longer than the combined length of the embolic implant 140 and the soft section 116. For example, the embolic implant 140 can have a length of between about 1 cm and about 60 cm, the soft section 116 can have a length of about 40 cm, and the introducer sheath can have a length that is about 5 cm longer than the sum of the embolic implant 140 length and the soft section 116 length, i.e. between about 46 cm and about 105 cm.
  • FIGs. 2A and 2B are illustrations of an exemplary implantation system such as illustrated in FIG. 1 interfacing with a microcatheter 200. FIG. 2A illustrates an instant of a treatment procedure near the beginning of the treatment procedure in which an introducer sheath 180 is positioned to cover an embolic implant 140 and a soft portion 116 of a delivery tube 110 in a packaged configuration and a distal end 184 of the introducer sheath 180 is mated or engaged with a proximal end of the microcatheter 200. As shown in FIG. 2A, the distal end 184 of the introducer sheath 180 can be sized to engage the microcatheter 200 to create an enclosed interface through which the embolic implant 140 and the soft portion 116 of the delivery tube 110 can pass. The embolic implant 140 and the delivery tube 110 can be translated distally to push the embolic implant 140 and a portion of the delivery tube 110 into the microcatheter 200.
  • FIG. 2B illustrates an instant of the treatment procedure in which the embolic implant 140 and the soft portion 116 are positioned within the microcatheter 200. At the instant illustrated in FIG. 2B, the embolic implant 140 and the soft portion 116 are protected by the microcatheter 200 and the introducer sheath can now be pulled proximally 180 or left in place as the delivery tube 110 and embolic implant 140 are further translated distally.
  • FIGs. 3A through 3C are illustrations of an exemplary implantation system during a series of example implantation steps. FIG. 3A illustrates an embolic implant 140 and a soft portion 116 of a delivery tube 110 positioned inside a microcatheter 200 and an introducer sheath 180 being translated proximally over a proximal portion 118 of the delivery tube 110. As illustrated in FIG. 3A, the introducer sheath 180 can be disengaged from the microcatheter 200 and pulled proximally once the embolic implant 140 and soft section 116 are protected within the microcatheter 200, but before the embolic implant 140 is positioned at a treatment site or within an aneurysm. Alternatively, the introducer sheath 180 can remain engaged to the microcatheter until the embolic implant 140 is positioned at the treatment site or ready to be deployed from the delivery tube 110 and then pulled proximally after the embolic implant 140 is positioned at the treatment site.
  • FIG. 3B illustrates the introducer sheath 180 in a deployment configuration in which the introducer sheath 180 is engaged with an interference feature 120 positioned near a proximal end 112 of the delivery tube 110. The introducer sheath 180 is shown providing a force F against the interference feature 120. The force can be sufficient to move the interference feature 120 proximally in relation to the delivery tube 110. Prior to the application of the force F, the interference feature 120 can be detachably attached to the proximal end 112 of the delivery tube 110, and the interference feature 120 can be detached from the proximal end 112 of the delivery tube 110 in response to the force F. Alternatively, the interference feature 120 can remain attached to the delivery tube 110 and the force F can be sufficient to move the interference feature 120 in relation to the delivery tube 110.
  • The introducer sheath 180 can be sized to engage the interference feature 120. As illustrated, the introducer sheath 180 can be tubular and can have a circular proximal end 182, and the interference feature 120 can protrude radially beyond a circumference of the delivery tube 110. The interference feature 120 can be circular, having a circumference larger than a circumference of the proximal end 182 of the introducer sheath 180. The interference feature 120 can provide a flat surface against which the proximal end 182 of the introducer sheath 180 can press. Additionally, or alternatively, the interference feature can have a non-flat surface that can have a slope or a groove for receiving the introducer sheath 180. The interference feature 120 can be a bump positioned near the distal end of the delivery tube that extends beyond the circumference of the delivery tube and extends so that the introducer sheath 180, when slid proximally over the delivery tube 110, must engage the interreference feature 120 before sliding completely over and off the proximal end 112 of the delivery tube 110.
  • FIG. 3C illustrates the interference feature 120 after being moved proximally in relation to the delivery tube 110 in response to the force F from the introducer sheath 180. The interference feature 120 can be attached to a pull wire 130, and the pull wire 130 can be pulled proximally when the interference feature 180 is moved proximally. The interference feature 120 can be detachably attached to the delivery tube 110 prior to the proximal movement of the interference feature 120, and a detachment feature 122 can be manipulated to facilitate the detachment of the interference feature 120. Once detached, the interference feature 120 can be pulled proximally away from the delivery tube 110, and the pull wire 130 can be moved to exit the proximal end 112 of the delivery tube 110 in response to the pulling of the interference feature 120. The pull wire 130 can be an elongated member that extends through a lumen of the delivery tube 110 toward the embolic implant 140. The pull wire 130 can constitute a component of a deployment system for releasing the embolic implant 140 at the distal end 114 of the delivery tube 110. When the pull wire 130 is pulled proximally, the pull wire 130 can initiate the deployment of the embolic implant 140. The embolic implant 140 can be detached from the delivery tube 110 in response to the proximal movement of the pull wire 130 in relation to the delivery tube 110.
  • FIG. 4A illustrates an exemplary implantation system having a breakable disconnection feature 122a. The implantation system can have an interference feature 120 detachably attached to a delivery tube 110 by the breakable disconnection feature 122a. The delivery tube 110 can include notches 115 that are areas in which material is removed from the delivery tube 110. The notches 115 can be positioned at a proximal end 112 of the delivery tube 110. The proximal end 112 of the delivery tube 110 can be attached to the interference feature 120 by gluing, welding, or other means. The notches 115 can be a breakable section 122a of the delivery tube 110. When an introducer sheath 180 is pressed against the interference feature 120, a force from the interference feature 120 can cause the breakable section 122a to break, and the interference feature 120 can then be moved proximally in relation to the delivery tube 110. The interference feature 120 can have a circular surface 124 against which the introducer sheath 180 can press. FIG. 4B is a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 4A.
  • FIG. 5A illustrates an exemplary implantation system having a twist-lock disconnection feature 122b. The implantation system can have a delivery tube 110 with groove 113 cut at a proximal end 112 and an interference feature 120 that has a bump 123 or another feature that can engage the groove 113. The interference feature 120 can be detachably attached to the delivery tube 110 by the twist-lock disconnection feature (and/or a bayonet connector) 122b. The interference feature 120 can extend within a lumen of the delivery tube 110 at the proximal end 112 of the delivery tube 110 and have a bump or protrusion 123 that can be positioned in the groove 113 in the delivery tube 110 to maintain the attachment between the interference feature 120 and the delivery tube 110. The bump or protrusion 123 can be slid through the groove 113 to detach the interference feature 120 from the delivery tube 110. The groove 113 can be L shaped, and the interference feature 120 can be twisted in relation to the delivery tube 110 and then pulled proximally in relation to the delivery tube 110 to disconnect the twist-lock disconnection feature 122b. FIG. 5B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 5A.
  • While FIGs. 4A through 5B illustrate examples of an interference feature 120 that is movable in relation to the delivery tube 110 after detaching from the delivery tube 110, the interference feature need not be detached, and can be movable in relation to the delivery tube 110 without detaching. FIGs. 6A through 8C illustrate example systems wherein the interference feature 120 remains at least partially attached to the delivery tube 110.
  • FIG. 6A illustrates an exemplary implantation system having a sliding track 113a and a bump or protrusion 123a. The sliding track 113a can be cut from a portion of the delivery tube 110 near the proximal end 112 of the delivery tube 110. The interference feature 120 can have an engagement bump or protrusion 123a that is positioned to slide within the track 113a. The track 113a can extend along a portion of a length of the delivery tube 110, and the bump 123a can slide within the track 113a, allowing the interference feature 120 to move in a proximal direction in relation to the delivery tube 110. The track 113a can be L shaped, and the interference feature 120 can be twisted in relation to the delivery tube 110 and then pulled proximally in relation to the delivery tube 110 to move the interference feature 120 in relation to the delivery tube 110. The interference feature 120 can be attached to a pull wire 130, and the movement of the interference feature 120 can move the pull wire 130 to deploy an embolic implant 140. FIG. 6B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 6A.
  • FIG. 7A illustrates an exemplary implantation system having a stretchable segment 126. The implantation system can have a delivery tube 110 with a stretchable segment 126 positioned near a proximal end 112 of the delivery tube 110. The stretchable segment 126 can be a region of the delivery tube 110 that has a propensity to stretch in response to a force that creates tension along a length of the delivery tube 110 that includes the stretchable segment 126. The stretchable segment 126 can include a coil that is compressed in an initial state as illustrated in FIG. 7A, a laser cut portion of the tube, and/or a portion of tubing having greater elasticity. The stretchable segment 126 can extends in response to a force provided by the introducer sheath 180 against the interference feature 120. The stretchable segment 126 can allow the pull wire and the interference feature 120 to move proximally in relation to the delivery tube 110 without the interference feature 120 becoming disconnected from the delivery tube 110. The stretchable segment 126 can have a fully extended length that is determined by the material properties and/or construction of the stretchable segment 126. The fully extended length can limit the distance that the interference feature 120 can be moved proximally in relation to the delivery tube 110. FIG. 7B illustrates a cross-sectional view near a proximal end of the exemplary implantation system as indicated in FIG. 7A.
  • FIGs. 8A through 8C illustrate an exemplary implantation system having a stretchable element 126a and a detachment feature 122c. The disconnection feature 122c illustrated in FIGs. 8A through 8C can include notches 115B in a delivery tube 110, similar to that illustrated in FIGs. 4 and 4B. It is contemplated that other disconnection features, including the disconnection features illustrated in, and described in relation to FIGs. 1, 3A-3C, 5, or 5B could be combined with a stretchable segment like those described herein or otherwise known. When used in combination with the stretchable segment 126a, the disconnection feature 122c can be positioned along a length of the delivery tube 110 at or near the stretchable segment 126a. Both the stretchable segment 126a and the disconnection feature 122c can be positioned near the proximal end 112 of the delivery tube 110.
  • FIG. 8A illustrates the stretchable element 126a positioned within a lumen of the delivery tube 110 near the proximal end 112 of the delivery tube 110. In FIG. 8A, the delivery tube 110 is illustrated cut-away to show coils of the stretchable element 126a within. In the configuration illustrated in FIG. 8A, interference feature 120 can be attached to the delivery tube 110 via the stretchable element 126a and the detachment feature 122c.
  • FIG. 8B illustrates an introducer sheath 180 moved proximally to engage the interference feature 120, break the detachment feature 122c, and begin to stretch the stretchable element 126a. The delivery tube 110 and the introducer sheath 180 are shown cut-away. A pull wire 130 can be positioned within the delivery tube 110. The pull wire 130 can be pulled proximally as the interference feature 120 is moved proximally. The stretchable element 126a can be attached to the interference feature 120 with a weld, adhesive, or other connection 125. The stretchable element 126a can be attached to the delivery tube 110 with a weld, adhesive, or other connection 127. After the detachment feature 122c is detached, the stretchable element 126a can maintain an attachment between the interference feature 120 and the delivery tube 110.
  • FIG. 8C illustrates the introducer sheath 180 moved further proximally to move the interference feature 120 and pull wire 130 further proximally and further stretch the stretchable element 126a. The stretchable element 126a can have a fully extended length that is determined by the material properties and/or construction of the stretchable element 126a. The fully extended length can limit the distance that the interference feature 120 can be moved proximally in relation to the delivery tube 110.
  • FIG. 9 illustrates relative dimensions of a delivery system, microcatheter, and introducer sheath as known in the art. Known delivery systems are typically 200 cm long, known microcatheters are typically 165 cm long, and known introducer sheaths are typically 130 cm long. In known practices, the introducer sheath is typically removed after an embolic implant and any sensitive portions of the delivery system are inserted into the microcatheter. According to known practices, an introducer sheath cannot remain around the delivery system during the deployment step of the embolic implant because the combined length of known microcatheters and introducers is several centimeters longer than known delivery systems. It is an aspect of the present invention to size a delivery system and an introducer sheath so that the introducer sheath can remain on the delivery system through the embolic implant deployment step. In example systems presented herein, an implantation system can include a delivery system, microcatheter, and introducer sheath, wherein the delivery system is longer than the combined length of the microcatheter and the introducer sheath.
  • An aneurysm can be treated with an implantation system such as any of the implantation systems disclosed herein in relation to the present invention by executing some or all the following steps, not necessarily in order. An implantation system 100 having an embolic implant 140, an introducer sheath 180, a delivery tube 110, an interference feature 120, and a pull wire 130 can be provided. The pull wire 130 can be affixed to the interference feature 120. The pull wire 130 can be positioned within a lumen of the delivery tube 110. The interference feature 120 can be attached to a proximal end 112 of the delivery tube 110. The embolic implant 140 can be attached at a distal end 114 of the delivery tube 110. The introducer sheath 180 can be positioned to encompass the embolic implant 140 and a first portion of the delivery tube 110. The first portion of the delivery tube 110 can comprise a soft section 116. The introducer sheath can be sized to have an end-to-end length that is longer by about 5 cm than a length measurable from a distal end 144 of the embolic implant 140 to a proximal end 117 of the soft section 116. The introducer sheath 180 can be sized so that the end-to-end length is between about 46 cm and about 105 cm. A microcatheter 200 can be provided. The introducer sheath 180 can be positioned to engage with the microcatheter 200 while maintaining the embolic implant 140 and the first portion of the delivery tube 110 within the introducer sheath 180. The embolic implant 140 and the delivery tube 110 can be translated distally to position the embolic implant 140 and the first portion of the delivery tube 110 within the microcatheter 200. The introducer sheath 180 can be slid proximally over the delivery tube 110. The introducer sheath 180 can be pulled proximally to apply a force from the introducer sheath 180 to the interference feature 120. The interference feature 120 and the pull wire 130 can be moved proximally in relation to the delivery tube 110 in response to the force. The interference feature 120 can be detached from the delivery tube 110. The embolic implant 140 can be detached from the delivery tube 110 in response to moving the interference feature 120 and the pull wire 130 proximally in relation to the delivery tube 110.
  • The descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention. As described herein, the invention contemplates many variations and modifications of the implantation system and associated methods, including alternative geometries of system components, alternative materials, additional or alternative method steps, etc. These modifications would be apparent to those having ordinary skill in the art to which this invention relates and are intended to be within the scope of the claims which follow.
  • The methods described herein may be not methods for the treatment of the human or animal body by surgery or therapy. For example, the methods may be ex vivo and/or in vitro methods e.g. methods taking place in a laboratory and/or for testing.
  • Embodiments
    1. 1. A method for treating an aneurysm comprising:
      • providing an implantation system comprising an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire;
      • affixing the pull wire to the interference feature;
      • positioning the pull wire within a lumen of the delivery tube;
      • attaching the interference feature to a proximal end of the delivery tube;
      • attaching the embolic implant at a distal end of the delivery tube;
      • positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube;
      • sliding the introducer sheath proximally over the delivery tube;
      • pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; and
      • moving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
    2. 2. The method of embodiment 1
      wherein the first portion of the delivery tube comprises a soft section, and
      wherein a first length is measurable from a distal end of the embolic implant to a proximal end of the soft section,
      the method further comprising sizing the introducer sheath to comprise a second length measurable from a distal end to a proximal end of the introducer sheath, the second length measuring greater than the first length by about 5 cm.
    3. 3. The method of embodiment 1 or embodiment 2 further comprising sizing the introducer sheath to comprise a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
    4. 4. The method of any one of the preceding embodiments further comprising detaching the embolic implant from the delivery tube in response to moving the interference feature and the pull wire proximally in relation to the delivery tube.
    5. 5. The method of any one of the preceding embodiments further comprising detaching the interference feature from the delivery tube.
    6. 6. The method of any one of the preceding embodiments further comprising:
      • providing a microcatheter;
      • positioning the introducer sheath to engage with the microcatheter while maintaining the embolic implant and the first portion of the delivery tube within the inducer sheath; and
        translating the embolic implant and the delivery tube distally to position the embolic implant and the first portion of the delivery tube within the microcatheter.

Claims (15)

  1. An implantation system comprising:
    a delivery tube comprising a lumen therethrough, a proximal end, and a distal end;
    an embolic coil detachably attached to the distal end of the delivery tube;
    an introducer sheath comprising a lumen therethrough sized to slidably receive the delivery tube and the embolic coil;
    an interference feature positioned approximate the proximal end of the delivery tube; and
    an elongated member disposed within the lumen of the delivery tube and attached to the interference feature,
    wherein the introducer sheath is translatable over the delivery tube from the distal end of the delivery tube to the proximal end of the delivery tube and is sized to engage the interference feature,
    wherein the interference feature is movable in relation to the delivery tube in response to a force applied by the introducer sheath against the interference feature, and
    wherein the elongated member is movable in relation to the delivery tube in response to a proximal movement of the interference feature.
  2. The system of claim 1 wherein the interference feature is detachable from the delivery tube and wherein the elongated member is movable to exit the proximal end of the delivery tube in response to a proximal movement of the detached interference feature.
  3. The system of claim 1 or claim 2
    wherein the delivery tube comprises a soft section disposed approximate the distal end of the delivery tube,
    wherein a first length is measurable from a distal end of the embolic coil to a proximal end of the soft section, and
    wherein the introducer sheath comprises a second length measurable from a distal end to a proximal end of the introducer sheath, the second length measuring greater than the first length by about 5 cm.
  4. The system of claim 3 further comprising a microcatheter comprising a third length measurable from a distal end to a proximal end of the microcatheter, and wherein the delivery tube comprises a fourth length measurable from the distal end to the proximal end of the delivery tube, the fourth length measuring greater than the sum of the third length and the second length.
  5. The system of any one of the preceding claims wherein the introducer sheath comprises a length of between about 46 cm to about 105 cm, the length measurable from a distal end to a proximal end of the introducer sheath.
  6. The system of any one of the preceding claims
    wherein the delivery tube comprises a soft section disposed approximate the distal end of the delivery tube, and
    wherein the introducer sheath is movable from a packaged configuration in which the introducer sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the introducer sheath is engaged with the interference feature.
  7. The system of any one of the preceding claims wherein the embolic coil is detachable from the delivery tube in response to a proximal movement of the elongated member in relation to the delivery tube.
  8. The system of any one of the preceding claims wherein the interference feature comprises a substantially circular surface positioned to engage the proximal end of the introducer sheath.
  9. An implantation assembly comprising:
    a delivery tube comprising a lumen therethrough, a proximal end, and a distal end;
    an embolic implant attached to the distal end of the delivery tube;
    a pull wire disposed within the lumen of the delivery tube and movable to detach the embolic implant from the delivery tube;
    an engagement bump disposed on a proximal end of the pull wire and positioned approximate the proximal end of the delivery tube; and
    a tubular sheath conveyable over the embolic implant and the delivery tube from a distal end of the embolic implant to the proximal end of the delivery tube, the tubular sheath sized to engage the engagement bump,
    wherein the engagement bump and the pull wire are movable in relation to the delivery tube in response to a force applied by the tubular sheath to the engagement bump.
  10. The assembly of claim 9
    wherein the delivery tube comprises a soft section extending proximally from the distal end of the delivery tube,
    wherein a first length is measurable from the distal end of the embolic implant to a proximal end of the soft section, and
    wherein the tubular sheath comprises a second length measurable from a distal end to a proximal end of the tubular sheath, the second length measuring greater than the first length by about 5 cm.
  11. The assembly of claim 10 further comprising a microcatheter comprising a third length measurable from a distal end to a proximal end of the microcatheter, and wherein the delivery tube comprises a fourth length measurable from the distal end of the delivery tube to the proximal end of the delivery tube, the fourth length measuring greater than the sum of the third length and the second length.
  12. The assembly of any one of claims 9 to 11
    wherein the delivery tube comprises a soft section extending proximally from the distal end of the delivery tube, and
    wherein the tubular sheath is movable from a packaged configuration in which the tubular sheath is positioned to completely encompass the soft section and the embolic coil to a deployment configuration in which the tubular sheath is engaged with the engagement bump.
  13. The assembly of any one of claims 9 to 12 wherein the engagement bump is detachable from the delivery tube in response to the force applied by the tubular sheath.
  14. The assembly of any one of claims 9 to 13 wherein pull wire is movable to detach the embolic implant from the delivery tube in response to the force applied by the tubular sheath.
  15. A method for treating an aneurysm comprising:
    providing an implantation system comprising an embolic implant, an introducer sheath, a delivery tube, an interference feature, and a pull wire;
    affixing the pull wire to the interference feature;
    positioning the pull wire within a lumen of the delivery tube;
    attaching the interference feature to a proximal end of the delivery tube;
    attaching the embolic implant at a distal end of the delivery tube;
    positioning the introducer sheath to encompass the embolic implant and a first portion of the delivery tube;
    sliding the introducer sheath proximally over the delivery tube;
    pulling the introducer sheath proximally to apply a force from the introducer sheath to the interference feature; and
    moving the interference feature and the pull wire proximally in relation to the delivery tube in response to the force.
EP19215318.7A 2018-12-12 2019-12-11 Systems for embolic implant detachment Active EP3666202B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16/218,342 US11147562B2 (en) 2018-12-12 2018-12-12 Systems and methods for embolic implant detachment

Publications (2)

Publication Number Publication Date
EP3666202A1 true EP3666202A1 (en) 2020-06-17
EP3666202B1 EP3666202B1 (en) 2021-11-03

Family

ID=68886885

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19215318.7A Active EP3666202B1 (en) 2018-12-12 2019-12-11 Systems for embolic implant detachment

Country Status (6)

Country Link
US (1) US11147562B2 (en)
EP (1) EP3666202B1 (en)
JP (1) JP7412997B2 (en)
KR (1) KR20200072433A (en)
CN (1) CN111297428A (en)
ES (1) ES2901928T3 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9918718B2 (en) 2014-08-08 2018-03-20 DePuy Synthes Products, Inc. Embolic coil delivery system with retractable mechanical release mechanism
US10806462B2 (en) 2017-12-21 2020-10-20 DePuy Synthes Products, Inc. Implantable medical device detachment system with split tube and cylindrical coupling
US11147562B2 (en) 2018-12-12 2021-10-19 DePuy Synthes Products, Inc. Systems and methods for embolic implant detachment
US11253265B2 (en) 2019-06-18 2022-02-22 DePuy Synthes Products, Inc. Pull wire detachment for intravascular devices
US11426174B2 (en) 2019-10-03 2022-08-30 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant mechanical release
US11207494B2 (en) 2019-07-03 2021-12-28 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant distal portion
US11672946B2 (en) * 2019-09-24 2023-06-13 Boston Scientific Scimed, Inc. Protection and actuation mechanism for controlled release of implantable embolic devices
US11376013B2 (en) 2019-11-18 2022-07-05 DePuy Synthes Products, Inc. Implant delivery system with braid cup formation
US11457922B2 (en) 2020-01-22 2022-10-04 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant distal portion
US11432822B2 (en) * 2020-02-14 2022-09-06 DePuy Synthes Products, Inc. Intravascular implant deployment system
US11951026B2 (en) 2020-06-30 2024-04-09 DePuy Synthes Products, Inc. Implantable medical device detachment system with flexible braid section
CN115942908A (en) 2020-08-21 2023-04-07 形状记忆医疗公司 Mechanical separation system for transcatheter device
KR20220130605A (en) * 2021-03-18 2022-09-27 디퍼이 신테스 프로덕츠, 인코포레이티드 Systems and methods for embolic implant detachment
CN114081568B (en) * 2021-11-19 2022-08-30 心凯诺医疗科技(上海)有限公司 Assembly comprising embolic material and delivery system therefor
US11844490B2 (en) 2021-12-30 2023-12-19 DePuy Synthes Products, Inc. Suture linkage for inhibiting premature embolic implant deployment
US11937824B2 (en) 2021-12-30 2024-03-26 DePuy Synthes Products, Inc. Implant detachment systems with a modified pull wire
US11937825B2 (en) 2022-03-02 2024-03-26 DePuy Synthes Products, Inc. Hook wire for preventing premature embolic implant detachment
US11937826B2 (en) 2022-03-14 2024-03-26 DePuy Synthes Products, Inc. Proximal link wire for preventing premature implant detachment
US20230293184A1 (en) * 2022-03-15 2023-09-21 DePuy Synthes Products, Inc. Interference feature for inhibiting premature embolic implant detachment
TW202400089A (en) * 2022-03-16 2024-01-01 美商西瑞维斯克公司 Systems and methods for the endovascular treatment of hydrocephalus and elevated intracranial pressure

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070010850A1 (en) * 2005-06-02 2007-01-11 Keith Balgobin Stretch resistant embolic coil delivery system with mechanical release mechanism
US20140277093A1 (en) * 2013-03-14 2014-09-18 Stryker Nv Operations Limited Vaso-occlusive device delivery system
US20150182227A1 (en) * 2013-12-27 2015-07-02 Blockade Medical, LLC Coil system
US20180325706A1 (en) * 2015-01-20 2018-11-15 Neurogami Medical, Inc. Vascular implant

Family Cites Families (213)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3429408A (en) 1967-04-25 1969-02-25 Associated Spring Corp Actuator sleeves for spring clutch
US5484409A (en) 1989-08-25 1996-01-16 Scimed Life Systems, Inc. Intravascular catheter and method for use thereof
US5122136A (en) 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5108407A (en) 1990-06-08 1992-04-28 Rush-Presbyterian St. Luke's Medical Center Method and apparatus for placement of an embolic coil
US5636639A (en) 1992-02-18 1997-06-10 Symbiosis Corporation Endoscopic multiple sample bioptome with enhanced biting action
US5263964A (en) 1992-05-06 1993-11-23 Coil Partners Ltd. Coaxial traction detachment apparatus and method
US5250071A (en) 1992-09-22 1993-10-05 Target Therapeutics, Inc. Detachable embolic coil assembly using interlocking clasps and method of use
US5350397A (en) 1992-11-13 1994-09-27 Target Therapeutics, Inc. Axially detachable embolic coil assembly
US5382259A (en) 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5334210A (en) 1993-04-09 1994-08-02 Cook Incorporated Vascular occlusion assembly
US5925059A (en) 1993-04-19 1999-07-20 Target Therapeutics, Inc. Detachable embolic coil assembly
US5569221A (en) 1994-07-07 1996-10-29 Ep Technologies, Inc. Catheter component bond and method
US6273404B1 (en) 1995-06-05 2001-08-14 Scimed Life Systems, Inc. Method of making monolithic hub and strain relief
US6168622B1 (en) 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US5899935A (en) 1997-08-04 1999-05-04 Schneider (Usa) Inc. Balloon expandable braided stent with restraint
US6203547B1 (en) 1997-12-19 2001-03-20 Target Therapeutics, Inc. Vaso-occlusion apparatus having a manipulable mechanical detachment joint and a method for using the apparatus
US6113622A (en) 1998-03-10 2000-09-05 Cordis Corporation Embolic coil hydraulic deployment system
US6835185B2 (en) 1998-12-21 2004-12-28 Micrus Corporation Intravascular device deployment mechanism incorporating mechanical detachment
US6391037B1 (en) 2000-03-02 2002-05-21 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6623504B2 (en) 2000-12-08 2003-09-23 Scimed Life Systems, Inc. Balloon catheter with radiopaque distal tip
US7018394B2 (en) * 2001-01-10 2006-03-28 Cordis Neurovascular, Inc. Embolic coil introducer system
US6454780B1 (en) 2001-06-21 2002-09-24 Scimed Life Systems, Inc. Aneurysm neck obstruction device
US8715312B2 (en) 2001-07-20 2014-05-06 Microvention, Inc. Aneurysm treatment device and method of use
US8252040B2 (en) 2001-07-20 2012-08-28 Microvention, Inc. Aneurysm treatment device and method of use
US20030195553A1 (en) 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US7608058B2 (en) 2002-07-23 2009-10-27 Micrus Corporation Stretch resistant therapeutic device
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US7208003B2 (en) * 2002-09-20 2007-04-24 Cordis Neurovascular, Inc. Reattachable introducer for a medical device deployment system
FR2853521B1 (en) * 2003-04-10 2005-12-02 Claude Mialhe DEVICE FOR EXPANDING A VESSEL AND INTRODUCING VASCULAR IMPLANT
US7371228B2 (en) 2003-09-19 2008-05-13 Medtronic Vascular, Inc. Delivery of therapeutics to treat aneurysms
US8182544B2 (en) 2003-10-08 2012-05-22 Codman & Shurtleff, Inc. Method for placing a medical agent into a vessel of the body
US9308382B2 (en) 2004-06-10 2016-04-12 Medtronic Urinary Solutions, Inc. Implantable pulse generator systems and methods for providing functional and/or therapeutic stimulation of muscles and/or nerves and/or central nervous system tissue
US20060025801A1 (en) 2004-07-30 2006-02-02 Robert Lulo Embolic device deployment system with filament release
US9655633B2 (en) 2004-09-10 2017-05-23 Penumbra, Inc. System and method for treating ischemic stroke
WO2006052322A2 (en) 2004-09-22 2006-05-18 Guterman Lee R Cranial aneurysm treatment arrangement
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
US8562672B2 (en) 2004-11-19 2013-10-22 Medtronic, Inc. Apparatus for treatment of cardiac valves and method of its manufacture
US20060116714A1 (en) 2004-11-26 2006-06-01 Ivan Sepetka Coupling and release devices and methods for their assembly and use
US8425550B2 (en) 2004-12-01 2013-04-23 Boston Scientific Scimed, Inc. Embolic coils
US7608089B2 (en) 2004-12-22 2009-10-27 Boston Scientific Scimed, Inc. Vaso-occlusive device having pivotable coupling
US20060206139A1 (en) 2005-01-19 2006-09-14 Tekulve Kurt J Vascular occlusion device
US7985238B2 (en) 2005-06-02 2011-07-26 Codman & Shurtleff, Inc. Embolic coil delivery system with spring wire release mechanism
US20060276825A1 (en) 2005-06-02 2006-12-07 Vladimir Mitelberg Stretch resistant embolic coil delivery system with mechanical release mechanism
US7377932B2 (en) 2005-06-02 2008-05-27 Cordis Neurovascular, Inc. Embolic coil delivery system with mechanical release mechanism
US7811305B2 (en) 2005-06-02 2010-10-12 Codman & Shurtleff, Inc. Stretch resistant embolic coil delivery system with spring release mechanism
US20060276827A1 (en) 2005-06-02 2006-12-07 Vladimir Mitelberg Stretch resistant embolic coil delivery system with mechanical release mechanism
US7367987B2 (en) 2005-06-02 2008-05-06 Cordis Neurovascular, Inc. Stretch resistant embolic coil delivery system with mechanical release mechanism
US7708755B2 (en) 2005-06-02 2010-05-04 Codman & Shurtleff Inc. Stretch resistant embolic coil delivery system with combined mechanical and pressure release mechanism
US7371251B2 (en) 2005-06-02 2008-05-13 Cordis Neurovascular, Inc. Stretch resistant embolic coil delivery system with mechanical release mechanism
US20060276830A1 (en) 2005-06-02 2006-12-07 Keith Balgobin Stretch resistant embolic coil delivery system with mechanical release mechanism
US20060276833A1 (en) 2005-06-02 2006-12-07 Keith Balgobin Stretch resistant embolic coil delivery system with spring assisted release mechanism
US7708754B2 (en) 2005-06-02 2010-05-04 Codman & Shurtleff, Pc Stretch resistant embolic coil delivery system with mechanical release mechanism
US7819892B2 (en) 2005-06-02 2010-10-26 Codman & Shurtleff, Inc. Embolic coil delivery system with spring wire release mechanism
US7819891B2 (en) 2005-06-02 2010-10-26 Codman & Shurtleff, Inc. Stretch resistant embolic coil delivery system with spring release mechanism
US7371252B2 (en) 2005-06-02 2008-05-13 Cordis Neurovascular, Inc. Stretch resistant embolic coil delivery system with mechanical release mechanism
US9636115B2 (en) 2005-06-14 2017-05-02 Stryker Corporation Vaso-occlusive delivery device with kink resistant, flexible distal end
AU2006262447A1 (en) 2005-06-20 2007-01-04 Medtronic Ablation Frontiers Llc Ablation catheter
US20070083132A1 (en) 2005-10-11 2007-04-12 Sharrow James S Medical device coil
US8066036B2 (en) 2005-11-17 2011-11-29 Microvention, Inc. Three-dimensional complex coil
US9757260B2 (en) 2006-03-30 2017-09-12 Medtronic Vascular, Inc. Prosthesis with guide lumen
US7766933B2 (en) 2006-03-31 2010-08-03 Codman & Shurtleff, Inc. Stretch resistant design for embolic coils with stabilization bead
US9615832B2 (en) 2006-04-07 2017-04-11 Penumbra, Inc. Aneurysm occlusion system and method
US8777979B2 (en) 2006-04-17 2014-07-15 Covidien Lp System and method for mechanically positioning intravascular implants
CA2655026C (en) 2006-06-15 2016-08-02 Microvention, Inc. Embolization device constructed from expansible polymer
US8062325B2 (en) 2006-07-31 2011-11-22 Codman & Shurtleff, Inc. Implantable medical device detachment system and methods of using the same
US8366720B2 (en) 2006-07-31 2013-02-05 Codman & Shurtleff, Inc. Interventional medical device system having an elongation retarding portion and method of using the same
US7901444B2 (en) 2006-09-29 2011-03-08 Codman & Shurtleff, Inc. Embolic coil delivery system with mechanical release mechanism
US20080306503A1 (en) 2006-11-20 2008-12-11 Boston Scientific Scimed, Inc. Mechanically detachable vaso-occlusive device
US8926650B2 (en) 2006-11-20 2015-01-06 Boston Scientific Scimed, Inc. Mechanically detachable vaso-occlusive device
WO2008074027A1 (en) 2006-12-13 2008-06-19 Biomerix Corporation Aneurysm occlusion devices
AU2008226694B8 (en) 2007-03-13 2013-06-20 Covidien Lp An implant including a coil and a stretch-resistant member
US8197442B2 (en) 2007-04-27 2012-06-12 Codman & Shurtleff, Inc. Interventional medical device system having a slotted section and radiopaque marker and method of making the same
EP2155077A2 (en) 2007-05-18 2010-02-24 Boston Scientific Scimed, Inc. Medical implant detachment systems
DE102007038446A1 (en) 2007-08-14 2009-02-19 pfm Produkte für die Medizin AG Embolisiereinrichtung
JP5698537B2 (en) 2007-12-21 2015-04-08 マイクロベンション インコーポレイテッド Hydrogel filament for biomedical use
US8974518B2 (en) 2008-03-25 2015-03-10 Medtronic Vascular, Inc. Eversible branch stent-graft and deployment method
EA201071225A1 (en) 2008-04-21 2011-06-30 Нфокус Ньюромедикал, Инк. DEVICES FOR EMBOLIZATION WITH REINFORCED GRID BELON AND SUPPLY SYSTEMS
US9572982B2 (en) 2008-04-30 2017-02-21 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US20090312748A1 (en) 2008-06-11 2009-12-17 Johnson Kirk L Rotational detachment mechanism
US8070694B2 (en) 2008-07-14 2011-12-06 Medtronic Vascular, Inc. Fiber based medical devices and aspiration catheters
US8333796B2 (en) 2008-07-15 2012-12-18 Penumbra, Inc. Embolic coil implant system and implantation method
US9232992B2 (en) 2008-07-24 2016-01-12 Aga Medical Corporation Multi-layered medical device for treating a target site and associated method
US8721714B2 (en) 2008-09-17 2014-05-13 Medtronic Corevalve Llc Delivery system for deployment of medical devices
EP2419166B1 (en) 2009-04-15 2017-11-22 MicroVention, Inc. Implant delivery system
JP2012523943A (en) 2009-04-20 2012-10-11 アチーバ メディカル リミテッド Occlusion device delivery assembly using a mechanically interlocking coupling mechanism
US8758423B2 (en) 2009-06-18 2014-06-24 Graftcraft I Goteborg Ab Device and method for treating ruptured aneurysms
WO2011038017A1 (en) 2009-09-22 2011-03-31 Penumbra, Inc. Manual actuation system for deployment of implant
CA2779483C (en) 2009-11-09 2018-03-13 Nfocus Neuromedical, Inc. Braid ball embolic device features
CN102188300B (en) * 2010-03-02 2014-05-28 上海微创医疗器械(集团)有限公司 Aneurismal surgical device
BR112012025969B1 (en) 2010-04-14 2021-01-05 Microvention, Inc. implant delivery device
US8764811B2 (en) 2010-04-20 2014-07-01 Medtronic Vascular, Inc. Controlled tip release stent graft delivery system and method
US8876878B2 (en) 2010-07-23 2014-11-04 Medtronic, Inc. Attachment mechanism for stent release
US8616040B2 (en) 2010-09-17 2013-12-31 Medtronic Vascular, Inc. Method of forming a drug-eluting medical device
CN103260665B (en) 2010-12-20 2015-08-19 微温森公司 Polymer support and manufacture method thereof
US20120283768A1 (en) 2011-05-05 2012-11-08 Sequent Medical Inc. Method and apparatus for the treatment of large and giant vascular defects
US9486604B2 (en) 2011-05-12 2016-11-08 Medtronic, Inc. Packaging and preparation tray for a delivery system
JP6026513B2 (en) 2011-05-13 2016-11-16 スパイレーション インコーポレイテッド ディー ビー エイ オリンパス レスピラトリー アメリカ Deployment catheter
WO2012158668A1 (en) 2011-05-17 2012-11-22 Stryker Corporation Method of fabricating an implantable medical device that includes one or more thin film polymer support layers
WO2012166467A1 (en) 2011-05-27 2012-12-06 Stryker Corporation Assembly for percutaneously inserting an implantable medical device, steering the device to a target location and deploying the device
US8734500B2 (en) * 2011-09-27 2014-05-27 DePuy Synthes Products, LLC Distal detachment mechanisms for vascular devices
US9750565B2 (en) 2011-09-30 2017-09-05 Medtronic Advanced Energy Llc Electrosurgical balloons
KR101968885B1 (en) 2012-03-16 2019-04-15 테루모 코퍼레이션 Stent and stent delivery device
US9833625B2 (en) 2012-03-26 2017-12-05 Medtronic, Inc. Implantable medical device delivery with inner and outer sheaths
US9717421B2 (en) 2012-03-26 2017-08-01 Medtronic, Inc. Implantable medical device delivery catheter with tether
US9155540B2 (en) 2012-03-30 2015-10-13 DePuy Synthes Products, Inc. Embolic coil detachment mechanism with heating element and kicker
US9242290B2 (en) 2012-04-03 2016-01-26 Medtronic Vascular, Inc. Method and apparatus for creating formed elements used to make wound stents
US9549832B2 (en) 2012-04-26 2017-01-24 Medtronic Vascular, Inc. Apparatus and methods for filling a drug eluting medical device via capillary action
US9700399B2 (en) 2012-04-26 2017-07-11 Medtronic Vascular, Inc. Stopper to prevent graft material slippage in a closed web stent-graft
US9149190B2 (en) 2012-07-17 2015-10-06 Stryker Corporation Notification system of deviation from predefined conditions
JP2015525653A (en) 2012-08-13 2015-09-07 マイクロベンション インコーポレイテッド Mold removal device
US20140058435A1 (en) 2012-08-21 2014-02-27 Donald K. Jones Implant delivery and release system
US9504476B2 (en) 2012-10-01 2016-11-29 Microvention, Inc. Catheter markers
EP2906254B1 (en) 2012-10-15 2020-01-08 Microvention, Inc. Polymeric treatment compositions
CN108354645A (en) 2012-11-13 2018-08-03 柯惠有限合伙公司 plugging device
US9539022B2 (en) 2012-11-28 2017-01-10 Microvention, Inc. Matter conveyance system
WO2014089390A1 (en) 2012-12-07 2014-06-12 Medtronic, Inc. Minimally invasive implantable neurostimulation system
WO2014107529A2 (en) 2013-01-03 2014-07-10 Jones Donald K Detachable coil release system and handle assembly
US10342546B2 (en) 2013-01-14 2019-07-09 Microvention, Inc. Occlusive device
US9539382B2 (en) 2013-03-12 2017-01-10 Medtronic, Inc. Stepped catheters with flow restrictors and infusion systems using the same
CN105228534B (en) 2013-03-14 2018-03-30 斯瑞克公司 Vascular occluding device induction system
ES2879634T3 (en) 2013-03-14 2021-11-22 Stryker Corp Vasoocclusive device delivery system
RU2015144005A (en) 2013-03-14 2017-04-19 ИНКЬЮМЕДКС Инк. IMPLANTS, METHODS FOR THEIR MANUFACTURE AND DEVICE AND METHODS FOR DELIVERY OF IMPLANTS TO THE PLOT OF THE AFFECTED PATIENT VESSEL
US9398966B2 (en) 2013-03-15 2016-07-26 Medtronic Vascular, Inc. Welded stent and stent delivery system
CN105142543B (en) 2013-03-15 2019-06-04 柯惠有限合伙公司 The conveying of Vascular implant and separating mechanism
KR102245406B1 (en) 2013-03-15 2021-04-28 테루모 코퍼레이션 Embolic protection device
US9833252B2 (en) 2013-03-15 2017-12-05 Microvention, Inc. Multi-component obstruction removal system and method
EP2988793B1 (en) 2013-04-22 2019-01-02 Stryker European Holdings I, LLC Method for drug loading hydroxyapatite coated implant surfaces
US9445928B2 (en) 2013-05-30 2016-09-20 Medtronic Vascular, Inc. Delivery system having a single handed deployment handle for a retractable outer sheath
US11291452B2 (en) 2013-06-26 2022-04-05 W. L. Gore & Associates, Inc. Medical device deployment system
US9662120B2 (en) 2013-08-23 2017-05-30 Cook Medical Technologies Llc Detachable treatment device delivery system utilizing compression at attachment zone
US9675782B2 (en) 2013-10-10 2017-06-13 Medtronic Vascular, Inc. Catheter pull wire actuation mechanism
US9795391B2 (en) 2013-10-25 2017-10-24 Medtronic Vascular, Inc. Tissue compression device with tension limiting strap retainer
EP3082660B1 (en) 2013-12-20 2020-01-22 Microvention, Inc. Device delivery system
EP3082939B1 (en) 2013-12-20 2020-12-02 MicroVention, Inc. Delivery adapter
US9788839B2 (en) 2014-02-14 2017-10-17 Cook Medical Technologies Llc Stable screw-type detachment mechanism
EP3128962B1 (en) 2014-04-08 2018-05-23 Stryker Corporation Implant delivery system
WO2015167997A1 (en) 2014-04-30 2015-11-05 Stryker Corporation Implant delivery system and method of use
US9060777B1 (en) 2014-05-28 2015-06-23 Tw Medical Technologies, Llc Vaso-occlusive devices and methods of use
US9668898B2 (en) 2014-07-24 2017-06-06 Medtronic Vascular, Inc. Stent delivery system having dynamic deployment and methods of manufacturing same
RU2017105842A (en) 2014-07-25 2018-08-27 Инкьюмедкс, Инк. COATED EMBOLIC SPIRALS
US9918718B2 (en) 2014-08-08 2018-03-20 DePuy Synthes Products, Inc. Embolic coil delivery system with retractable mechanical release mechanism
US9770577B2 (en) 2014-09-15 2017-09-26 Medtronic Xomed, Inc. Pressure relief for a catheter balloon device
NZ728984A (en) 2014-09-17 2022-08-26 Artio Medical Inc Expandable body device and method of use
US9579484B2 (en) 2014-09-19 2017-02-28 Medtronic Vascular, Inc. Sterile molded dispenser
GB2533087B (en) 2014-12-08 2018-08-08 Cook Medical Technologies Llc Medical implant detachment mechanism and introducer assembly
US9692557B2 (en) 2015-02-04 2017-06-27 Stryker European Holdings I, Llc Apparatus and methods for administering treatment within a bodily duct of a patient
US10888331B2 (en) * 2015-02-10 2021-01-12 Boston Scientific Scimed, Inc. Active release of embolic coils
EP3266389A4 (en) 2015-03-03 2018-11-21 Kaneka Medix Corporation Vascular embolization tool and production method therefor
EP3291773A4 (en) 2015-05-07 2019-05-01 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Temporary interatrial shunts
US9717503B2 (en) 2015-05-11 2017-08-01 Covidien Lp Electrolytic detachment for implant delivery systems
US10398874B2 (en) 2015-05-29 2019-09-03 Covidien Lp Catheter distal tip configuration
US10154905B2 (en) 2015-08-07 2018-12-18 Medtronic Vascular, Inc. System and method for deflecting a delivery catheter
US10307168B2 (en) 2015-08-07 2019-06-04 Terumo Corporation Complex coil and manufacturing techniques
EP3334354B1 (en) 2015-08-11 2021-03-03 Terumo Corporation System for implant delivery
EP3349669B1 (en) 2015-09-18 2020-10-21 Terumo Corporation Vessel prosthesis
WO2017049314A1 (en) 2015-09-18 2017-03-23 Microvention, Inc. Pushable implant delivery system
CN108260342B (en) 2015-09-18 2021-07-30 微仙美国有限公司 Releasable delivery system
CN113952095A (en) 2015-09-18 2022-01-21 微仙美国有限公司 Implant retention, detachment and delivery system
ES2788738T3 (en) 2015-09-21 2020-10-22 Stryker Corp Embolectomy devices
WO2017053287A1 (en) 2015-09-21 2017-03-30 Stryker Corporation Embolectomy devices
US10172632B2 (en) 2015-09-22 2019-01-08 Medtronic Vascular, Inc. Occlusion bypassing apparatus with a re-entry needle and a stabilization tube
US10631869B2 (en) 2015-10-06 2020-04-28 Boston Scientific Scimed, Inc. Pusher arm and ball release mechanism for embolic coils
US10327791B2 (en) 2015-10-07 2019-06-25 Medtronic Vascular, Inc. Occlusion bypassing apparatus with a re-entry needle and a distal stabilization balloon
WO2017062383A1 (en) 2015-10-07 2017-04-13 Stryker Corporation Multiple barrel clot removal devices
US10786302B2 (en) 2015-10-09 2020-09-29 Medtronic, Inc. Method for closure and ablation of atrial appendage
US9700322B2 (en) 2015-10-14 2017-07-11 Three Rivers Medical Inc. Mechanical embolization delivery apparatus and methods
US10271873B2 (en) 2015-10-26 2019-04-30 Medtronic Vascular, Inc. Sheathless guide catheter assembly
US11090055B2 (en) 2015-10-30 2021-08-17 Incumedx Inc. Devices and methods for delivering an implant to a vascular disorder
US20170147765A1 (en) 2015-11-19 2017-05-25 Penumbra, Inc. Systems and methods for treatment of stroke
US10631946B2 (en) 2015-11-30 2020-04-28 Penumbra, Inc. System for endoscopic intracranial procedures
EP3386580B1 (en) 2015-12-09 2023-11-01 Medtronic Vascular Inc. Catheter with a lumen shaped as an identification symbol
US10159568B2 (en) 2015-12-14 2018-12-25 Medtronic, Inc. Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis
US10500046B2 (en) 2015-12-14 2019-12-10 Medtronic, Inc. Delivery system having retractable wires as a coupling mechanism and a deployment mechanism for a self-expanding prosthesis
ES2913227T3 (en) 2015-12-30 2022-06-01 Stryker Corp embolic devices
US20170189033A1 (en) 2016-01-06 2017-07-06 Microvention, Inc. Occlusive Embolic Coil
US10070950B2 (en) 2016-02-09 2018-09-11 Medtronic Vascular, Inc. Endoluminal prosthetic assemblies, and associated systems and methods for percutaneous repair of a vascular tissue defect
AU2017217879B9 (en) 2016-02-10 2021-08-19 Microvention, Inc. Intravascular treatment site access
CA3014316A1 (en) 2016-02-10 2017-08-17 Microvention, Inc. Devices for vascular occlusion
US10188500B2 (en) 2016-02-12 2019-01-29 Medtronic Vascular, Inc. Stent graft with external scaffolding and method
US10485579B2 (en) 2016-02-25 2019-11-26 Indian Wells Medical, Inc. Steerable endoluminal punch
US20170258476A1 (en) 2016-03-08 2017-09-14 Terumo Kabushiki Kaisha Blood vessel treatment method
US20170281331A1 (en) 2016-03-31 2017-10-05 Medtronic Vascular, Inc. Endoluminal prosthetic devices having fluid-absorbable compositions for repair of a vascular tissue defect
EP4112111A1 (en) 2016-03-31 2023-01-04 Medtronic Vascular Inc. Expandable introducer sheath
US10695542B2 (en) 2016-04-04 2020-06-30 Medtronic Vascular, Inc. Drug coated balloon
US10252024B2 (en) 2016-04-05 2019-04-09 Stryker Corporation Medical devices and methods of manufacturing same
US10441407B2 (en) 2016-04-12 2019-10-15 Medtronic Vascular, Inc. Gutter filling stent-graft and method
US9987122B2 (en) 2016-04-13 2018-06-05 Medtronic Vascular, Inc. Iliac branch device and method
US10010403B2 (en) 2016-04-18 2018-07-03 Medtronic Vascular, Inc. Stent-graft prosthesis and method of manufacture
US20170304097A1 (en) 2016-04-21 2017-10-26 Medtronic Vascular, Inc. Stent-graft delivery system having an inner shaft component with a loading pad or covering on a distal segment thereof for stent retention
JP6924256B2 (en) 2016-04-25 2021-08-25 ストライカー コーポレイションStryker Corporation Pre-installed reversing tractor thrombectomy device and method
US10940294B2 (en) 2016-04-25 2021-03-09 Medtronic Vascular, Inc. Balloon catheter including a drug delivery sheath
US10517711B2 (en) 2016-04-25 2019-12-31 Medtronic Vascular, Inc. Dissection prosthesis system and method
EP3448278B1 (en) 2016-04-25 2020-05-13 Stryker Corporation Inverting mechanical thrombectomy apparatus
EP3590446B1 (en) 2016-04-25 2021-01-06 Stryker Corporation Anti-jamming and macerating thrombectomy apparatuses
US10406011B2 (en) 2016-04-28 2019-09-10 Medtronic Vascular, Inc. Implantable medical device delivery system
US10191615B2 (en) 2016-04-28 2019-01-29 Medtronic Navigation, Inc. Method and apparatus for image-based navigation
US11147952B2 (en) 2016-04-28 2021-10-19 Medtronic Vascular, Inc. Drug coated inflatable balloon having a thermal dependent release layer
FR3050635A1 (en) 2016-05-02 2017-11-03 Univ Strasbourg INFLATABLE AND DETACHABLE BALLOON FOR USE IN A BODY CAVITY, TREATMENT NECESSARY AND DRAINING METHOD THEREOF
US10292844B2 (en) 2016-05-17 2019-05-21 Medtronic Vascular, Inc. Method for compressing a stented prosthesis
JP6803929B2 (en) 2016-06-01 2020-12-23 マイクロベンション インコーポレイテッドMicrovention, Inc. Improved reinforced balloon catheter
US10285710B2 (en) 2016-06-01 2019-05-14 DePuy Synthes Products, Inc. Endovascular detachment system with flexible distal end and heater activated detachment
ES2924974T3 (en) 2016-06-03 2022-10-13 Stryker Corp Reversal Thrombectomy Apparatus
US10646689B2 (en) 2016-07-29 2020-05-12 Cephea Valve Technologies, Inc. Mechanical interlock for catheters
EP3490464A4 (en) 2016-07-29 2020-07-29 Wallaby Medical, Inc. Implant delivery systems and methods
WO2018053314A1 (en) 2016-09-16 2018-03-22 Greg Mirigian Occlusive implants with fiber-based release structures
US10258492B2 (en) * 2017-03-03 2019-04-16 Cook Medical Technologies Llc Prosthesis delivery system with axially collapsible sheath
US10806462B2 (en) 2017-12-21 2020-10-20 DePuy Synthes Products, Inc. Implantable medical device detachment system with split tube and cylindrical coupling
US11305095B2 (en) 2018-02-22 2022-04-19 Scientia Vascular, Llc Microfabricated catheter having an intermediate preferred bending section
US10806461B2 (en) 2018-04-27 2020-10-20 DePuy Synthes Products, Inc. Implantable medical device detachment system with split tube
US10631791B2 (en) 2018-06-25 2020-04-28 Caption Health, Inc. Video clip selector for medical imaging and diagnosis
WO2020093012A1 (en) 2018-11-01 2020-05-07 Terumo Corporation Occlusion systems
US11147562B2 (en) 2018-12-12 2021-10-19 DePuy Synthes Products, Inc. Systems and methods for embolic implant detachment
US11207494B2 (en) 2019-07-03 2021-12-28 DePuy Synthes Products, Inc. Medical device delivery member with flexible stretch resistant distal portion

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070010850A1 (en) * 2005-06-02 2007-01-11 Keith Balgobin Stretch resistant embolic coil delivery system with mechanical release mechanism
US20140277093A1 (en) * 2013-03-14 2014-09-18 Stryker Nv Operations Limited Vaso-occlusive device delivery system
US20150182227A1 (en) * 2013-12-27 2015-07-02 Blockade Medical, LLC Coil system
US20180325706A1 (en) * 2015-01-20 2018-11-15 Neurogami Medical, Inc. Vascular implant

Also Published As

Publication number Publication date
ES2901928T3 (en) 2022-03-24
EP3666202B1 (en) 2021-11-03
KR20200072433A (en) 2020-06-22
JP2020093099A (en) 2020-06-18
JP7412997B2 (en) 2024-01-15
US20200187951A1 (en) 2020-06-18
US11147562B2 (en) 2021-10-19
CN111297428A (en) 2020-06-19

Similar Documents

Publication Publication Date Title
EP3666202A1 (en) Systems and methods for embolic implant detachment
US20210196281A1 (en) Systems and methods for embolic implant detachment
US11826051B2 (en) Implantable medical device detachment system with split tube and cylindrical coupling
US7608099B2 (en) Medical appliance delivery apparatus and method of use
US20220117606A1 (en) Pull wire detachment for intravascular devices
US10159489B2 (en) Systems and methods for delivering multiple embolization coils
EP3865079A1 (en) Intravascular implant deployment system
US20030083730A1 (en) Loading cartridge for self-expanding stent
EP4059446A1 (en) Systems and methods for embolic implant detachment
US20230310005A1 (en) Systems and methods for embolic implant deployment
US20230200819A1 (en) Systems and methods for embolic implant deployment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20201217

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20210209

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BLUMENSTYK, DAVID

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20210721

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1443277

Country of ref document: AT

Kind code of ref document: T

Effective date: 20211115

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602019008943

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20211103

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1443277

Country of ref document: AT

Kind code of ref document: T

Effective date: 20211103

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2901928

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20220324

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220203

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220303

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220303

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220203

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20220204

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602019008943

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20211231

26N No opposition filed

Effective date: 20220804

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211211

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20191211

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221231

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20221231

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20231110

Year of fee payment: 5

Ref country code: IE

Payment date: 20231109

Year of fee payment: 5

Ref country code: FR

Payment date: 20231108

Year of fee payment: 5

Ref country code: DE

Payment date: 20231031

Year of fee payment: 5

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20240118

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20211103